Literature DB >> 18278811

Mechanisms of apoptosis resistance and treatment strategies to overcome them in hormone-refractory prostate cancer.

Robert G Uzzo1, Naomi B Haas, Paul L Crispen, Vladimir M Kolenko.   

Abstract

New therapeutic strategies are needed to improve treatment outcomes in men with hormone-refractory prostate cancer. A better understanding of the molecular mechanisms of cell death in response to therapeutic strategies will help avoid ineffective treatment regimens and provide a molecular basis for new therapeutic modalities targeting apoptosis-resistant forms of prostate cancer. In this review, the authors focused on the established aberrations of apoptosis in hormone-refractory prostate cancer, and they have described novel treatment strategies to overcome apoptosis resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18278811     DOI: 10.1002/cncr.23318

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Synergistic effect of allyl isothiocyanate (AITC) on cisplatin efficacy in vitro and in vivo.

Authors:  Xiang Ling; David Westover; Felicia Cao; Shousong Cao; Xiang He; Hak-Ryul Kim; Yuesheng Zhang; Daniel Cf Chan; Fengzhi Li
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

2.  Role of DNA methyltransferase 1 in hormone-resistant prostate cancer.

Authors:  Miao-Fen Chen; Wen-Cheng Chen; Yu-Jia Chang; Ching-Fang Wu; Chun-Te Wu
Journal:  J Mol Med (Berl)       Date:  2010-06-12       Impact factor: 4.599

3.  The androgen-regulated Calcium-Activated Nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in vitro.

Authors:  Josefine Gerhardt; Corinna Steinbrech; Oralea Büchi; Silvia Behnke; Annette Bohnert; Florian Fritzsche; Heike Liewen; Frank Stenner; Peter Wild; Thomas Hermanns; Michael Müntener; Manfred Dietel; Klaus Jung; Carsten Stephan; Glen Kristiansen
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

4.  p21/Cip1 and p27/Kip1 Are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer.

Authors:  Srirupa Roy; Mallikarjuna Gu; Kumaraguruparan Ramasamy; Rana P Singh; Chapla Agarwal; Sunitha Siriwardana; Robert A Sclafani; Rajesh Agarwal
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

5.  Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer.

Authors:  Roger S Jackson; William Placzek; Ana Fernandez; Shabnam Ziaee; Chia-Yi Chu; Jun Wei; John Stebbins; Shinichi Kitada; Gloria Fritz; John C Reed; Leland W Chung; Maurizio Pellecchia; Neil A Bhowmick
Journal:  Neoplasia       Date:  2012-07       Impact factor: 5.715

6.  Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.

Authors:  Toshiro Migita; Stacey Ruiz; Alessandro Fornari; Michelangelo Fiorentino; Carmen Priolo; Giorgia Zadra; Fumika Inazuka; Chiara Grisanzio; Emanuele Palescandolo; Eyoung Shin; Christopher Fiore; Wanling Xie; Andrew L Kung; Phillip G Febbo; Aravind Subramanian; Lorelei Mucci; Jing Ma; Sabina Signoretti; Meir Stampfer; William C Hahn; Stephen Finn; Massimo Loda
Journal:  J Natl Cancer Inst       Date:  2009-03-24       Impact factor: 13.506

7.  Matrix protein CCN1 is critical for prostate carcinoma cell proliferation and TRAIL-induced apoptosis.

Authors:  Carrie A Franzen; Chih-Chiun Chen; Viktor Todorović; Vladislava Juric; Ricardo I Monzon; Lester F Lau
Journal:  Mol Cancer Res       Date:  2009-07-07       Impact factor: 5.852

8.  The effect of 5-aminolevulinic acid and its derivatives on protoporphyrin IX accumulation and apoptotic cell death in castrate-resistant prostate cancer cells.

Authors:  Ervin Teper; Peter Makhov; Konstantin Golovine; Daniel J Canter; Cynthia B Myers; Alexander Kutikov; Steven N Sterious; Robert G Uzzo; Vladimir M Kolenko
Journal:  Urology       Date:  2012-08-28       Impact factor: 2.649

9.  SP600125 enhances C-2-induced cell death by the switch from autophagy to apoptosis in bladder cancer cells.

Authors:  Haiyang Yu; Chun-Li Wu; Xiangyu Wang; Qianhong Ban; Chunhua Quan; Mengbo Liu; Hangqi Dong; Jinfeng Li; Gi-Young Kim; Yung Hyun Choi; Zhenya Wang; Cheng-Yun Jin
Journal:  J Exp Clin Cancer Res       Date:  2019-11-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.